Disseminated Aspergillus terreus infection arising from cutaneous inoculation treated with caspofungin

Clinical Microbiology and Infection

Volumn 9, Issue 12, 2003, Pages 1238-1241

  Cooke, Fiona J ^a   Terpos, E ^a   Boyle, J ^a   Rahemtulla, A ^a   Rogers, T R ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Aspergillus terreus; Candin; Cutaneous; Immunosuppressed

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; DEXAMETHASONE; DOXORUBICIN; FLUCONAZOLE; GENTAMICIN; ITRACONAZOLE; PIPERACILLIN PLUS TAZOBACTAM; VINCRISTINE;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS TERREUS; CASE REPORT; DEBRIDEMENT; FUNGUS ISOLATION; HUMAN; IN VITRO STUDY; INOCULATION; MALE; MYELOMA; NEUTROPENIA; PATIENT CARE; PRIORITY JOURNAL; SKIN; STEM CELL TRANSPLANTATION;

ASPERGILLUS; ASPERGILLUS TERREUS; FUNGI;

EID: 0346339450     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2003.00797.x     Document Type: Article

References (17)

1. Szekely A, Johnson EM, Warnock DW. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of moulds. J Clin Microbiol 1999; 37: 1480-3.
2. Iwen PC, Rupp ME, Langas AN. Invasive pulmonary aspergillosis due to Aspergillus terreus; 12-year experience and review of the literature. Clin Infect Dis 1998; 26: 1092-7.
3. Tritz DM, Woods GL. Fatal disseminated infection with Aspergillus terreus in immunocompromised hosts. Clin Infect Dis 1993; 16: 118-22.
4. Sutton DA, Sanche SE, Revankar SG et al. In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole. J Clin Microbiol 1999; 37: 2343-5.
5. Silva ME, Malogolowkin MH, Hall TR et al. Mycotic aneurysm of the thoracic aorta due to Aspergillus terreus: case report and review of the literature. Clin Infect Dis 2000; 31: 1144-8.
6. Drexler L, Rytel M, Keelan M et al. Aspergillus terreus infective endocarditis on a porcine heterograft valve. J Thorac Cardiovasc Surg 1980; 79: 269-74.
7. Russack V. Aspergillus terreus myocarditis: report of a case and review of the literature. Am J Cardiovasc Pathol 1990; 3: 275-9.
8. Stein SC, Corrado ML, Friedlander M et al. Chronic meningitis with spinal involvement (arachnoiditis). Ann Neurol 1982; 11: 519-24.
9. Glotzbach RE. Aspergillus terreus infection of pseudoaneurysm of aorto-femoral vascular graft with contiguous vertebral osteomyelitis. Am J Clin Pathol 1982; 77: 224-7.
10. Park KU, Lee HS, Kim CJ et al. Fungal discitis due to Aspergillus terreus in a patient with acute lymphoblastic leukaemia. J Korean Med Sci 2000; 15: 704-5.
11. Mahgoub ES, Ismail SA, El Hassan AM. Cervical lymphadenitis caused by Aspergillus terreus. BMJ 1969; 1: 689-90.
12. Van Burik JH, Colven R, Spach DH. Cutaneous aspergillosis. J Clin Microbiol 1998; 36: 3115-21.
13. Suseelan AV, Gugnani HC, Ojukwu JO. Primary cutaneous aspergillosis due to Aspergillus terreus. Arch Dermatol 1976; 112: 1468.
14. Lass-Florl C, Rath P, Niederwieseri D et al. Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants. J Hosp Infect 2000; 46: 31-5.
15. Rogers TR. Antifungal resistance: does it matter? Int J Infect Dis 2002; 6: S47-53.
16. Lass-Florl C, Kofler G, Kropshofer G et al. In vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 1998; 42: 497-502.
17. MSD. Summary of product characteristics. http://www.merck.com